InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
1
T+90 hit rate
25%
T+90 mean return
+7.6%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Franchini Indrani Lall, Responsable de la Conformité. Officer active across 4 companies, notably ALEXION PHARMACEUTICALS, INC.. Aggregated, 11 reports have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €673k. History available since 8 June 2021. The latest transaction was filed on 2 January 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations11 total
12,003 shares0Common StockSEC:0001606498-25-000012:0
878 shares0Common StockSEC:0001735276-24-000016:0
5,175 shares0Common StockSEC:0001735276-24-000002:0
3,500 shares@ US$210.00100.0% of flowCommon StockSEC:0001735276-23-000038:0
5,175 shares0Common StockSEC:0001735276-23-000007:0
116,075 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000066
116,075 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000066:0
26,812 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000056
26,812 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000056:0
●
928 shares@ US$177.0050.0% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-21-000048:0
●
928 shares@ US$177.0050.0% of flowCommon Stock, par value $.0001 per shareSEC:0000899866-21-000048
11 of 11 declarations
About Franchini Indrani Lall
Indrani Lall Franchini is the Executive Vice President and Chief Compliance Officer at ALEXION PHARMACEUTICALS, INC. She is responsible for regulatory compliance and risk management. Franchini brings valuable expertise, contributing to the company's sustainability and reputation.
